qinghai ye - Search Results

Year	Number of Results
2002	1
2003	2
2004	6
2005	2
2006	5
2007	9
2008	8
2009	6
2010	7
2011	6
2012	12
2013	14
2014	9
2015	8
2016	11
2017	3
2018	5
2019	6
2020	9
2021	2
2022	7
2023	7
2024	1

1

IL-6/JAK1 pathway drives PD-L1 Y112 phosphorylation to promote cancer immune evasion.

Chan LC, Li CW, Xia W, Hsu JM, Lee HH, Cha JH, Wang HL, Yang WH, Yen EY, Chang WC, Zha Z, Lim SO, Lai YJ, Liu C, Liu J, Dong Q, Yang Y, Sun L, Wei Y, Nie L, Hsu JL, Li H, Ye Q, Hassan MM, Amin HM, Kaseb AO, Lin X, Wang SC, Hung MC. Chan LC, et al. Among authors: ye q. J Clin Invest. 2019 Jul 15;129(8):3324-3338. doi: 10.1172/JCI126022. eCollection 2019 Jul 15. J Clin Invest. 2019. PMID: 31305264 Free PMC article.

2

GTPBP4 promotes hepatocellular carcinoma progression and metastasis via the PKM2 dependent glucose metabolism.

Zhou Q, Yin Y, Yu M, Gao D, Sun J, Yang Z, Weng J, Chen W, Atyah M, Shen Y, Ye Q, Li CW, Hung MC, Dong Q, Zhou C, Ren N. Zhou Q, et al. Among authors: ye q. Redox Biol. 2022 Oct;56:102458. doi: 10.1016/j.redox.2022.102458. Epub 2022 Sep 10. Redox Biol. 2022. PMID: 36116159 Free PMC article.

3

PARG inhibition limits HCC progression and potentiates the efficacy of immune checkpoint therapy.

Yu M, Chen Z, Zhou Q, Zhang B, Huang J, Jin L, Zhou B, Liu S, Yan J, Li X, Zhang W, Liu C, Hu B, Fu P, Zhou C, Xu Y, Xiao Y, Zhou J, Fan J, Ren N, Hung MC, Guo L, Li H, Ye Q. Yu M, et al. Among authors: ye q. J Hepatol. 2022 Jul;77(1):140-151. doi: 10.1016/j.jhep.2022.01.026. Epub 2022 Feb 12. J Hepatol. 2022. PMID: 35157958

4

CRKL dictates anti-PD-1 resistance by mediating tumor-associated neutrophil infiltration in hepatocellular carcinoma.

Xie P, Yu M, Zhang B, Yu Q, Zhao Y, Wu M, Jin L, Yan J, Zhou B, Liu S, Li X, Zhou C, Zhu X, Huang C, Xu Y, Xiao Y, Zhou J, Fan J, Hung MC, Ye Q, Guo L, Li H. Xie P, et al. Among authors: ye q. J Hepatol. 2024 Feb 23:S0168-8278(24)00129-6. doi: 10.1016/j.jhep.2024.02.009. Online ahead of print. J Hepatol. 2024. PMID: 38403027

5

MET Inhibitors Promote Liver Tumor Evasion of the Immune Response by Stabilizing PDL1.

Li H, Li CW, Li X, Ding Q, Guo L, Liu S, Liu C, Lai CC, Hsu JM, Dong Q, Xia W, Hsu JL, Yamaguchi H, Du Y, Lai YJ, Sun X, Koller PB, Ye Q, Hung MC. Li H, et al. Among authors: ye q. Gastroenterology. 2019 May;156(6):1849-1861.e13. doi: 10.1053/j.gastro.2019.01.252. Epub 2019 Jan 31. Gastroenterology. 2019. PMID: 30711629 Free PMC article.

6

Hepatoma cell-intrinsic TLR9 activation induces immune escape through PD-L1 upregulation in hepatocellular carcinoma.

Zhou B, Yan J, Guo L, Zhang B, Liu S, Yu M, Chen Z, Zhang K, Zhang W, Li X, Xu Y, Xiao Y, Zhou J, Fan J, Hung MC, Li H, Ye Q. Zhou B, et al. Among authors: ye q. Theranostics. 2020 May 17;10(14):6530-6543. doi: 10.7150/thno.44417. eCollection 2020. Theranostics. 2020. PMID: 32483468 Free PMC article.

7

Recent advances of GOLM1 in hepatocellular carcinoma.

Yan J, Zhou B, Li H, Guo L, Ye Q. Yan J, et al. Among authors: ye q. Hepat Oncol. 2020 Jun 29;7(2):HEP22. doi: 10.2217/hep-2020-0006. Hepat Oncol. 2020. PMID: 32647567 Free PMC article. Review.

8

Whole-exome sequencing reveals the metastatic potential of hepatocellular carcinoma from the perspective of tumor and circulating tumor DNA.

Zhou C, Weng J, Liu S, Zhou Q, Hu Z, Yin Y, Lv P, Sun J, Li H, Yi Y, Shen Y, Ye Q, Shi Y, Dong Q, Liu C, Zhu X, Ren N. Zhou C, et al. Among authors: ye q. Hepatol Int. 2023 Dec;17(6):1461-1476. doi: 10.1007/s12072-023-10540-x. Epub 2023 May 23. Hepatol Int. 2023. PMID: 37217808

9

Robotic versus open surgery for simultaneous resection of rectal cancer and liver metastases: a randomized controlled trial.

Chang W, Ye Q, Xu D, Liu Y, Zhou S, Ren L, He G, Zhou G, Liang F, Fan J, Wei Y, Wang X, Xu J. Chang W, et al. Among authors: ye q. Int J Surg. 2023 Nov 1;109(11):3346-3353. doi: 10.1097/JS9.0000000000000581. Int J Surg. 2023. PMID: 37800563 Free PMC article. Clinical Trial.

10

Anatomical resection improves relapse-free survival in colorectal liver metastases in patients with KRAS/NRAS/BRAF mutations or right-sided colon cancer: a retrospective cohort study.

Chang W, Chen Y, Zhou S, Ren L, Xu Y, Zhu D, Tang W, Ye Q, Wang X, Fan J, Wei Y, Xu J. Chang W, et al. Among authors: ye q. Int J Surg. 2023 Oct 1;109(10):3070-3077. doi: 10.1097/JS9.0000000000000562. Int J Surg. 2023. PMID: 37526097 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

132 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

132 results

Results by year